Crossref
Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib
Synfacts · 01.09.2026 · 22 (09) · 877
DOI: 10.1055/a-2915-0287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synfacts, erschienen am 01.09.2026. Verfasst von Mark Lautens und 1 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lautens, M., & Durant, A. G. (2026). Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib. Synfacts, 22(09), 877. https://doi.org/10.1055/a-2915-0287
Vancouver
Lautens M, Durant AG. Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib. Synfacts. 2026;22(09):877. doi:10.1055/a-2915-0287
BibTeX
@article{Lautens2026,
author = {Lautens, Mark and Durant, Andrew G.},
title = {Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib},
journal = {Synfacts},
year = {2026},
volume = {22},
number = {09},
pages = {877},
doi = {10.1055/a-2915-0287}
}
EUVIMED